2020-2025 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Publisher Name :
Date: 20-Apr-2021
No. of pages: 101

This report elaborates the market size, market characteristics, and market growth of the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) industry, and breaks down according to the type, application, and consumption area of Pharmaceutical Contract Development and Manufacturing Organization (CDMO). The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pharmaceutical Contract Development and Manufacturing Organization (CDMO) in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market covered in Chapter 13:

Famar SA

Covance Inc.

Boehringer Ingelheim Group

PAREXEL International Corporation

Aenova Holding GmbH

Lonza Group

Baxter Biopharma Solutions

Jubilant Life Sciences Ltd.

Novotech Pty Ltd.

Syneos Health Inc.

LSK Global Pharma Service Co Ltd.

Catalent Inc.

Patheon Inc.

Pfizer CentreSource

CMIC Holdings Co. Ltd

Pharmaceutical Product Development LLC

Recipharm AB

In Chapter 6, on the basis of types, the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market from 2015 to 2025 is primarily split into:

Active Pharmaceutical Ingredient (API) Manufacturing

Finished Dosage Formulation (FDF) Development

and Manufacturing

Secondary Packaging

In Chapter 7, on the basis of applications, the Pharmaceutical Contract Development and Manufacturing Organization (CDMO) market from 2015 to 2025 covers:

Preclinical

Phase I

Phase II

Phase III

Phase IV

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:

United States

Europe

China

Japan

India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:

North America (Covered in Chapter 8)

United States

Canada

Mexico

Europe (Covered in Chapter 9)

Germany

UK

France

Italy

Spain

Others

Asia-Pacific (Covered in Chapter 10)

China

Japan

India

South Korea

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 11)

Saudi Arabia

UAE

South Africa

Others

South America (Covered in Chapter 12)

Brazil

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

2020-2025 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Table of Content

1 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Research Scope
1.1 Study Goals
1.2 Market Definition and Scope
1.3 Key Market Segments
1.4 Study and Forecasting Years

2 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Research Methodology
2.1 Methodology
2.2 Research Data Source
2.2.1 Secondary Data
2.2.2 Primary Data
2.2.3 Market Size Estimation
2.2.4 Legal Disclaimer

3 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forces
3.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
3.2 Top Impacting Factors (PESTEL Analysis)
3.2.1 Political Factors
3.2.2 Economic Factors
3.2.3 Social Factors
3.2.4 Technological Factors
3.2.5 Environmental Factors
3.2.6 Legal Factors
3.3 Industry Trend Analysis
3.4 Industry Trends Under COVID-19
3.4.1 Risk Assessment on COVID-19
3.4.2 Assessment of the Overall Impact of COVID-19 on the Industry
3.4.3 Pre COVID-19 and Post COVID-19 Market Scenario
3.5 Industry Risk Assessment

4 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Geography
4.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Value and Market Share by Regions
4.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value ($) by Region (2015-2020)
4.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Market Share by Regions (2015-2020)
4.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Production and Market Share by Major Countries
4.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production by Major Countries (2015-2020)
4.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Market Share by Major Countries (2015-2020)
4.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Market Share by Regions
4.3.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Regions (2015-2020)
4.3.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Regions (2015-2020)

5 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Trade Statistics
5.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import
5.2 United States Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.3 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.4 China Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.5 Japan Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.6 India Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
5.7 ...

6 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Type
6.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production and Market Share by Types (2015-2020)
6.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production by Types (2015-2020)
6.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Market Share by Types (2015-2020)
6.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value and Market Share by Types (2015-2020)
6.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value by Types (2015-2020)
6.2.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Market Share by Types (2015-2020)
6.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2015-2020)
6.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of Finished Dosage Formulation (FDF) Development (2015-2020)
6.5 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of and Manufacturing (2015-2020)
6.6 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production, Price and Growth Rate of Secondary Packaging (2015-2020)

7 Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - By Application
7.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Market Share by Applications (2015-2020)
7.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Applications (2015-2020)
7.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Applications (2015-2020)
7.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Preclinical (2015-2020)
7.3 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase I (2015-2020)
7.4 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase II (2015-2020)
7.5 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase III (2015-2020)
7.6 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate of Phase IV (2015-2020)

8 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market
8.1 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.2 United States Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.3 Canada Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.4 Mexico Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
8.5 The Influence of COVID-19 on North America Market

9 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
9.1 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.2 Germany Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.3 United Kingdom Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.4 France Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.5 Italy Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.6 Spain Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
9.7 The Influence of COVID-19 on Europe Market

10 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
10.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.2 China Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.3 Japan Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.4 South Korea Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.5 Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.6 India Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
10.7 The Influence of COVID-19 on Asia Pacific Market

11 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
11.1 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.2 Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.3 UAE Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.4 South Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
11.5 The Influence of COVID-19 on Middle East and Africa Market

12 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis
12.1 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
12.2 Brazil Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size
12.3 The Influence of COVID-19 on South America Market

13 Company Profiles
13.1 Famar SA
13.1.1 Famar SA Basic Information
13.1.2 Famar SA Product Profiles, Application and Specification
13.1.3 Famar SA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.2 Covance Inc.
13.2.1 Covance Inc. Basic Information
13.2.2 Covance Inc. Product Profiles, Application and Specification
13.2.3 Covance Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.3 Boehringer Ingelheim Group
13.3.1 Boehringer Ingelheim Group Basic Information
13.3.2 Boehringer Ingelheim Group Product Profiles, Application and Specification
13.3.3 Boehringer Ingelheim Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.4 PAREXEL International Corporation
13.4.1 PAREXEL International Corporation Basic Information
13.4.2 PAREXEL International Corporation Product Profiles, Application and Specification
13.4.3 PAREXEL International Corporation Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.5 Aenova Holding GmbH
13.5.1 Aenova Holding GmbH Basic Information
13.5.2 Aenova Holding GmbH Product Profiles, Application and Specification
13.5.3 Aenova Holding GmbH Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.6 Lonza Group
13.6.1 Lonza Group Basic Information
13.6.2 Lonza Group Product Profiles, Application and Specification
13.6.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.7 Baxter Biopharma Solutions
13.7.1 Baxter Biopharma Solutions Basic Information
13.7.2 Baxter Biopharma Solutions Product Profiles, Application and Specification
13.7.3 Baxter Biopharma Solutions Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.8 Jubilant Life Sciences Ltd.
13.8.1 Jubilant Life Sciences Ltd. Basic Information
13.8.2 Jubilant Life Sciences Ltd. Product Profiles, Application and Specification
13.8.3 Jubilant Life Sciences Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.9 Novotech Pty Ltd.
13.9.1 Novotech Pty Ltd. Basic Information
13.9.2 Novotech Pty Ltd. Product Profiles, Application and Specification
13.9.3 Novotech Pty Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.10 Syneos Health Inc.
13.10.1 Syneos Health Inc. Basic Information
13.10.2 Syneos Health Inc. Product Profiles, Application and Specification
13.10.3 Syneos Health Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.11 LSK Global Pharma Service Co Ltd.
13.11.1 LSK Global Pharma Service Co Ltd. Basic Information
13.11.2 LSK Global Pharma Service Co Ltd. Product Profiles, Application and Specification
13.11.3 LSK Global Pharma Service Co Ltd. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.12 Catalent Inc.
13.12.1 Catalent Inc. Basic Information
13.12.2 Catalent Inc. Product Profiles, Application and Specification
13.12.3 Catalent Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.13 Patheon Inc.
13.13.1 Patheon Inc. Basic Information
13.13.2 Patheon Inc. Product Profiles, Application and Specification
13.13.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.14 Pfizer CentreSource
13.14.1 Pfizer CentreSource Basic Information
13.14.2 Pfizer CentreSource Product Profiles, Application and Specification
13.14.3 Pfizer CentreSource Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.15 CMIC Holdings Co. Ltd
13.15.1 CMIC Holdings Co. Ltd Basic Information
13.15.2 CMIC Holdings Co. Ltd Product Profiles, Application and Specification
13.15.3 CMIC Holdings Co. Ltd Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.16 Pharmaceutical Product Development LLC
13.16.1 Pharmaceutical Product Development LLC Basic Information
13.16.2 Pharmaceutical Product Development LLC Product Profiles, Application and Specification
13.16.3 Pharmaceutical Product Development LLC Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)
13.17 Recipharm AB
13.17.1 Recipharm AB Basic Information
13.17.2 Recipharm AB Product Profiles, Application and Specification
13.17.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Performance (2015-2020)

14 Market Forecast - By Regions
14.1 North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.2 Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.4 Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)
14.5 South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast (2020-2025)

15 Market Forecast - By Type and Applications
15.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast by Types (2020-2025)
15.1.1 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Production and Market Share by Types (2020-2025)
15.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Value and Market Share by Types (2020-2025)
15.2 Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast by Applications (2020-2025)

List of Tables and Figures

Figure Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Picture
Table Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Key Market Segments
Figure Study and Forecasting Years
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size and Growth Rate 2015-2025
Figure Industry PESTEL Analysis
Figure Global COVID-19 Status
Figure Market Size Forecast Comparison of Pre COVID-19 and Post COVID-19
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value ($) and Growth Rate (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value ($) by Countries (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Market Share by Regions (2015-2020)
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Market Share by Regions in 2019
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production and Growth Rate (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production by Major Countries (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Market Share by Major Countries (2015-2020)
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Market Share by Regions in 2019
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption and Growth Rate (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Regions (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Regions (2015-2020)
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Regions in 2019
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export Top 3 Country 2019
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Import Top 3 Country 2019
Table United States Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
Table Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
Table China Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
Table Japan Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
Table India Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Export and Import (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production by Types (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Market Share by Types (2015-2020)
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Production Share by Type (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value by Types (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Market Share by Types (2015-2020)
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Value Share by Type (2015-2020)
Figure Global Active Pharmaceutical Ingredient (API) Manufacturing Production and Growth Rate (2015-2020)
Figure Global Active Pharmaceutical Ingredient (API) Manufacturing Price (2015-2020)
Figure Global Finished Dosage Formulation (FDF) Development Production and Growth Rate (2015-2020)
Figure Global Finished Dosage Formulation (FDF) Development Price (2015-2020)
Figure Global and Manufacturing Production and Growth Rate (2015-2020)
Figure Global and Manufacturing Price (2015-2020)
Figure Global Secondary Packaging Production and Growth Rate (2015-2020)
Figure Global Secondary Packaging Price (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Applications (2015-2020)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Applications (2015-2020)
Figure Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Share by Application (2015-2020)
Figure Global Preclinical Consumption and Growth Rate (2015-2020)
Figure Global Phase I Consumption and Growth Rate (2015-2020)
Figure Global Phase II Consumption and Growth Rate (2015-2020)
Figure Global Phase III Consumption and Growth Rate (2015-2020)
Figure Global Phase IV Consumption and Growth Rate (2015-2020)
Figure North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Table North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Countries (2015-2020)
Table North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure United States Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Canada Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Mexico Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure North America COVID-19 Status
Figure Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Table Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Countries (2015-2020)
Table Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure Germany Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure United Kingdom Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure France Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Italy Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Spain Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Europe COVID-19 Status
Figure Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Table Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Countries (2015-2020)
Table Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure China Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Japan Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure South Korea Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure India Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure Asia Pacific COVID-19 Status
Figure Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Table Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Countries (2015-2020)
Table Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure UAE Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure South Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Figure South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Table South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption by Countries (2015-2020)
Table South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure South America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Consumption Market Share by Countries (2015-2020)
Figure Brazil Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Consumption and Growth Rate (2015-2020)
Table Famar SA Company Profile
Table Famar SA Production, Value, Price, Gross Margin 2015-2020
Figure Famar SA Production and Growth Rate
Figure Famar SA Value ($) Market Share 2015-2020
Table Covance Inc. Company Profile
Table Covance Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Covance Inc. Production and Growth Rate
Figure Covance Inc. Value ($) Market Share 2015-2020
Table Boehringer Ingelheim Group Company Profile
Table Boehringer Ingelheim Group Production, Value, Price, Gross Margin 2015-2020
Figure Boehringer Ingelheim Group Production and Growth Rate
Figure Boehringer Ingelheim Group Value ($) Market Share 2015-2020
Table PAREXEL International Corporation Company Profile
Table PAREXEL International Corporation Production, Value, Price, Gross Margin 2015-2020
Figure PAREXEL International Corporation Production and Growth Rate
Figure PAREXEL International Corporation Value ($) Market Share 2015-2020
Table Aenova Holding GmbH Company Profile
Table Aenova Holding GmbH Production, Value, Price, Gross Margin 2015-2020
Figure Aenova Holding GmbH Production and Growth Rate
Figure Aenova Holding GmbH Value ($) Market Share 2015-2020
Table Lonza Group Company Profile
Table Lonza Group Production, Value, Price, Gross Margin 2015-2020
Figure Lonza Group Production and Growth Rate
Figure Lonza Group Value ($) Market Share 2015-2020
Table Baxter Biopharma Solutions Company Profile
Table Baxter Biopharma Solutions Production, Value, Price, Gross Margin 2015-2020
Figure Baxter Biopharma Solutions Production and Growth Rate
Figure Baxter Biopharma Solutions Value ($) Market Share 2015-2020
Table Jubilant Life Sciences Ltd. Company Profile
Table Jubilant Life Sciences Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Jubilant Life Sciences Ltd. Production and Growth Rate
Figure Jubilant Life Sciences Ltd. Value ($) Market Share 2015-2020
Table Novotech Pty Ltd. Company Profile
Table Novotech Pty Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure Novotech Pty Ltd. Production and Growth Rate
Figure Novotech Pty Ltd. Value ($) Market Share 2015-2020
Table Syneos Health Inc. Company Profile
Table Syneos Health Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Syneos Health Inc. Production and Growth Rate
Figure Syneos Health Inc. Value ($) Market Share 2015-2020
Table LSK Global Pharma Service Co Ltd. Company Profile
Table LSK Global Pharma Service Co Ltd. Production, Value, Price, Gross Margin 2015-2020
Figure LSK Global Pharma Service Co Ltd. Production and Growth Rate
Figure LSK Global Pharma Service Co Ltd. Value ($) Market Share 2015-2020
Table Catalent Inc. Company Profile
Table Catalent Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Catalent Inc. Production and Growth Rate
Figure Catalent Inc. Value ($) Market Share 2015-2020
Table Patheon Inc. Company Profile
Table Patheon Inc. Production, Value, Price, Gross Margin 2015-2020
Figure Patheon Inc. Production and Growth Rate
Figure Patheon Inc. Value ($) Market Share 2015-2020
Table Pfizer CentreSource Company Profile
Table Pfizer CentreSource Production, Value, Price, Gross Margin 2015-2020
Figure Pfizer CentreSource Production and Growth Rate
Figure Pfizer CentreSource Value ($) Market Share 2015-2020
Table CMIC Holdings Co. Ltd Company Profile
Table CMIC Holdings Co. Ltd Production, Value, Price, Gross Margin 2015-2020
Figure CMIC Holdings Co. Ltd Production and Growth Rate
Figure CMIC Holdings Co. Ltd Value ($) Market Share 2015-2020
Table Pharmaceutical Product Development LLC Company Profile
Table Pharmaceutical Product Development LLC Production, Value, Price, Gross Margin 2015-2020
Figure Pharmaceutical Product Development LLC Production and Growth Rate
Figure Pharmaceutical Product Development LLC Value ($) Market Share 2015-2020
Table Recipharm AB Company Profile
Table Recipharm AB Production, Value, Price, Gross Margin 2015-2020
Figure Recipharm AB Production and Growth Rate
Figure Recipharm AB Value ($) Market Share 2015-2020
Figure North America Market Consumption and Growth Rate Forecast (2020-2025)
Figure Europe Market Consumption and Growth Rate Forecast (2020-2025)
Figure Asia-Pacific Market Consumption and Growth Rate Forecast (2020-2025)
Figure Middle East and Africa Market Consumption and Growth Rate Forecast (2020-2025)
Figure South America Market Consumption and Growth Rate Forecast (2020-2025)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Production by Types (2020-2025)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Production Share by Types (2020-2025)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Value ($) by Types (2020-2025)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Value Share by Types (2020-2025)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Consumption by Applications (2020-2025)
Table Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast Consumption Share by Applications (2020-2025)
  • Global Healthcare Workforce Management System Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 86
    Workforce management is an institutional process that maximizes performance levels and competency for an organization. The process includes all The activities needed to maintain a productive workforce, such as field service management, human resource management, performance and training management, data collection, recruiting, budgeting, forecasting, scheduling and analytics. Workforce management provides a common set of performance-based tools and software to support corporate mana......
  • Global Life Science Analytics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Life Science Analytics market size was valued at US$ 23410 million in 2023. With growing demand in downstream market, the Life Science Analytics is forecast to a readjusted size of US$ 47330 million by 2030 with a CAGR of 10.6% during review period. The research report highlights the growth potential of the global Life Science Analytics market. Life Science Analytics are expected to show stable growth in the future market. Ho......
  • Global Patient Engagement Solutions Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 116
    According to our LPI (LP Information) latest study, the global Patient Engagement Solutions market size was valued at US$ 14090 million in 2023. With growing demand in downstream market, the Patient Engagement Solutions is forecast to a readjusted size of US$ 53040 million by 2030 with a CAGR of 20.9% during review period. The research report highlights the growth potential of the global Patient Engagement Solutions market. Patient Engagement Solutions are expected to show stable growth ......
  • Global Operating Room Management Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 117
    According to our LPI (LP Information) latest study, the global Operating Room Management market size was valued at US$ 4314.6 million in 2023. With growing demand in downstream market, the Operating Room Management is forecast to a readjusted size of US$ 6494.7 million by 2030 with a CAGR of 6.0% during review period. The research report highlights the growth potential of the global Operating Room Management market. Operating Room Management are expected to show stable growth in the futu......
  • Global Healthcare Supply Chain Managements Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Healthcare Supply Chain Managements market size was valued at US$ 2151.2 million in 2023. With growing demand in downstream market, the Healthcare Supply Chain Managements is forecast to a readjusted size of US$ 4098.9 million by 2030 with a CAGR of 9.6% during review period. The research report highlights the growth potential of the global Healthcare Supply Chain Managements market. Healthcare Supply Chain Managements are ex......
  • Global Healthcare Workforce Management System Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 108
    According to our LPI (LP Information) latest study, the global Healthcare Workforce Management System market size was valued at US$ 1543.3 million in 2023. With growing demand in downstream market, the Healthcare Workforce Management System is forecast to a readjusted size of US$ 3331.2 million by 2030 with a CAGR of 11.6% during review period. The research report highlights the growth potential of the global Healthcare Workforce Management System market. Healthcare Workforce Management ......
  • Global Behavioral Health Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Behavioral Health Software market size was valued at US$ 1641 million in 2023. With growing demand in downstream market, the Behavioral Health Software is forecast to a readjusted size of US$ 3274.7 million by 2030 with a CAGR of 10.4% during review period. The research report highlights the growth potential of the global Behavioral Health Software market. Behavioral Health Software are expected to show stable growth in the f......
  • Global Long-term Care Software Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Long-term Care Software market size was valued at US$ 1339.2 million in 2023. With growing demand in downstream market, the Long-term Care Software is forecast to a readjusted size of US$ 3460.2 million by 2030 with a CAGR of 14.5% during review period. The research report highlights the growth potential of the global Long-term Care Software market. Long-term Care Software are expected to show stable growth in the future mark......
  • Global Healthcare RCM Outsourcing Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 110
    According to our LPI (LP Information) latest study, the global Healthcare RCM Outsourcing market size was valued at US$ 19580 million in 2023. With growing demand in downstream market, the Healthcare RCM Outsourcing is forecast to a readjusted size of US$ 40390 million by 2030 with a CAGR of 10.9% during review period. The research report highlights the growth potential of the global Healthcare RCM Outsourcing market. Healthcare RCM Outsourcing are expected to show stable growth in the f......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs